Complete MAZE Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
MAZE Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 10 peer companies in Healthcare
P/E Ratio
$-175.85
-1475.2%
Peer Median: 62.2x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.4x
P/S Ratio
$0.53
-95.8%
Peer Median: 9.3x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for MAZE's business model and current situation.
Multiple Comparison
Multiple | MAZE Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -4.5x | 62.2x | 62.2x | -107.3% | Undervalued |
EV/EBITDA | Infinityx | 45.4x | 45.4x | Infinity% | Overvalued |
P/S Ratio | 224.0x | 9.3x | 8.6x | 2304.4% | Overvalued |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$0.66B | 0.0x | 0.0x | 2.4x | |
$0.69B | 0.0x | 0.0x | 0.0x | |
$0.59B | 0.0x | 0.0x | 0.0x | |
$0.45B | 0.0x | 0.0x | 9.3x | |
$0.56B | 0.0x | 0.0x | 224.0x | |
$0.55B | 0.0x | 0.0x | 1.3x | |
$0.50B | 0.0x | 0.0x | 12.4x | |
$0.37B | 0.0x | 0.0x | 19.7x | |
$0.41B | 0.0x | 0.0x | 0.5x | |
$727.24B | 62.2x | 45.4x | 14.8x |